Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation.
Tsunetsugu-Yokota Y, Kobayahi-Ishihara M, Wada Y, Terahara K, Takeyama H, Kawana-Tachikawa A, Tokunaga K, Yamagishi M, Martinez JP, Meyerhans A. Tsunetsugu-Yokota Y, et al. Among authors: wada y. Front Microbiol. 2016 Dec 1;7:1944. doi: 10.3389/fmicb.2016.01944. eCollection 2016. Front Microbiol. 2016. PMID: 27990142 Free PMC article.
EFP Analyzer: A fast, accurate, and easy-to-teach program for analyzing Extracellular Field Potentials from iPSC-derived cardiomyocytes.
Patel N, Shen A, Wada Y, Blair M, Mitchell D, Vanags L, Woo S, Ku M, Dauda K, Morris W, Yang M, Knollmann BC, Roden DM, Salem JE, Glazer AM, Kroncke BM. Patel N, et al. Among authors: wada y. bioRxiv [Preprint]. 2024 Oct 24:2024.10.21.619481. doi: 10.1101/2024.10.21.619481. bioRxiv. 2024. PMID: 39484468 Free PMC article. Preprint.
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice.
Kajimoto E, Nagasu H, Takasu M, Kishi S, Wada M, Tatsugawa R, Hirano A, Iwakura T, Umeno R, Wada Y, Itano S, Kadoya H, Kidokoro K, Sasaki T, Kashihara N. Kajimoto E, et al. Among authors: wada y. Sci Rep. 2024 Nov 2;14(1):26438. doi: 10.1038/s41598-024-77577-2. Sci Rep. 2024. PMID: 39488570 Free PMC article.
Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response.
Kuzuya T, Kawabe N, Muto H, Tachi Y, Ukai T, Wada Y, Komura G, Nakano T, Tanaka H, Nakaoka K, Ohno E, Funasaka K, Nagasaka M, Miyahara R, Hirooka Y. Kuzuya T, et al. Among authors: wada y. Curr Oncol. 2024 Oct 16;31(10):6218-6231. doi: 10.3390/curroncol31100463. Curr Oncol. 2024. PMID: 39451767 Free PMC article.
3,718 results